Already Proven Technologies Can Help Healthcare by Increasing Prescription
Accuracy, Reducing Fraud and Saving Lives
DETROIT, Dec. 17 /PRNewswire-FirstCall/ -- Compuware Corporation
(Nasdaq: CPWR) today announced that Compuware Covisint's Chief Security
Officer, David Miller, recently testified before the United States Senate
Committee on the Judiciary regarding "Electronic Prescribing of Controlled
Substances: Addressing Health Care and Law Enforcement Priorities." Miller
addressed Senator Sheldon Whitehouse (D-R.I.), outlining how technology
already developed by Covisint and proven on a wide-scale could help solve
many problems associated with the paper-based prescribing of controlled
substances.
Paper-based Challenges
Current regulations require that healthcare providers manually sign
prescriptions. These regulations address the three historic concerns with
e- prescribing: 1) authentication (identifying a signer); 2)
non-repudiation (ensuring the recipient that the electronic signature is
valid); and 3) record integrity (ensuring that a prescription was not
altered subsequent to being authenticated/signed).
Miller's advance Senate testimony, available at
http://judiciary.senate.gov/testimony.cfm?id=3042&wit_id=6795, outlined the
disadvantages of the current, paper-based prescription system, noting:
"Paper transactions are hard to track and manage ... involve manual
processes that are particularly vulnerable to human error ... and are
difficult to store and retrieve." He also noted that current methods are
subject to "a declining adherence" since healthcare providers are asked to
simultaneously support both paper- and electronic-based prescribing
processes.
E-based Cure
Covisint's secure, on-demand infrastructure--proven for years in other
industries--overcomes e-prescribing's historic challenges by securely
enabling the real-time sharing of information to patients, healthcare
organizations and communities. Covisint streamlines clinical and
administrative processes and enables the secure access to, and the improved
visibility of, health information. Covisint's ability to address and solve
e-prescribing obstacles can help ensure patient safety and efficiency and
provide the necessary safeguards to support the widespread adoption of
e-prescribing.
"E-prescribing controlled substances is not only a good idea, but also
imperative in an effort to solve many of the existing--yet unnecessary--
frauds, abuses, inaccuracies and errors in play for healthcare today,"
Miller said. "Covisint will continue to work hard to help bring safer, more
trusted and more secure technologies to improve healthcare, increase
efficiencies and save lives. These are exciting times, with much
opportunity to use technology to make a positive difference benefiting so
many people."
Miller was part of a panel that also included Laura Adams, President
and CEO of the Rhode Island Quality Institute; Kevin Hutchinson, President
and CEO of SureScripts; and Mike Podgurski, Vice President, Pharmacy
Services for Rite Aid Corporation. Panel members were chosen for their
individual expertise on this issue; Miller's primary role was to discuss
how technology already in use could help solve many of the problems
associated with today's paper-based system. Senator Whitehouse led the
discussion that built the case to move forward with e-prescribing of
controlled substances.
Covisint currently connects 45,800 organizations worldwide. Covisint's
highly available platform provides an on-demand infrastructure for secure
collaboration, interoperability and access to information. Covisint
streamlines and automates business processes, globally connecting business
communities, organizations and systems in the manufacturing, healthcare,
public sector and financial services industries.
Compuware Corporation
Compuware Corporation maximizes the value IT brings to the business by
helping CIOs more effectively manage the business of IT. Compuware
solutions accelerate the development, improve the quality and enhance the
performance of critical business systems while enabling CIOs to align and
govern the entire IT portfolio, increasing efficiency, cost control and
employee productivity throughout the IT organization. Founded in 1973,
Compuware serves the world's leading IT organizations, including more than
90 percent of the Fortune 100 companies. Learn more about Compuware at
http://www.compuware.com/.
Press Contact
Doug Anter, Compuware Communications and Investor Relations, 313-227-0127,
doug.anter@compuware.com
For Sales and Marketing Information
Compuware Corporation, One Campus Martius, Detroit, MI 48226,
800-521-9353, http://www.compuware.com
SOURCE Compuware Corporation
 back to top
Related links:
http://www.compuware.com
http://www.prnewswire.com/comp/112310.html /
CONTACT:
Doug Anter, Compuware Communications and
Investor Relations, +1-313-227-0127, doug.anter@compuware.com;
Compuware Corporation, +1-800-521- 9353
|
